NeuroLight Appoints Dr. Frank Nagy as Chief Clinical Officer and Director of Business Development
Pomona, New York — September 30, 2025 — NeuroLight, Inc., a pioneering neurotechnology company developing breakthrough brain state transfer solutions for neurological disorders, today announced the appointment of Frank Nagy, PhD, as Chief Clinical Officer and Director of Business Development. Dr. Nagy brings over a decade of experience in medical affairs leadership and clinical development […]
NeuroLight Appoints Geoffrey Lawrence as Chief Financial Officer
A seasoned finance leader to spearhead capital strategy as company advances non-pharmacological sleep technology
NeuroLight Appoints Dr. Jumaah Goldberg as Chief Strategy Officer to Accelerate Commercialization of Breakthrough Brain State Transfer Technology
Strategic Biotech/MedTech Leader Brings 18 Years of Neuroscience Innovation Experience to Revolutionary Neuromodulation Platform.
Leading Medical Device Expert Dr. Manish Vaishya Joins NeuroLight’s Advisory Board to Advance Revolutionary Technology for Transplanting Brain States
NeuroLight, Inc. is pleased to announce the appointment of Kai Peterson as our new Director of Non-dilutive Funding and Grants.
Kai Peterson joins NeuroLight as Director of Non-dilutive Funding and Grants
NeuroLight, Inc. is pleased to announce the appointment of Kai Peterson as our new Director of Non-dilutive Funding and Grants.
NeuroLight Presents Groundbreaking Insights on Sleep Stage Transitions at ASCS 2025
Pomona, New York — April 2025 — NeuroLight, Inc. is pleased to announce the successful presentation of its latest research at the Annual Advances in Sleep and Circadian Science (ASCS) Conference held in Florida by the Sleep Research Society (SRS). Dr. Antony Passaro, NeuroLight’s Lead Neuroscientist, presented the poster “Characterizing EEG Spectral Dynamics Across Sleep […]
Prof. Jeffry Lansman Joins Advisory Board of NeuroLight, Inc.
Pomona, New York — February 19, 2025 — NeuroLight, Inc., a pioneering neuromodulation medical device company, today announced the appointment of Jeffry B. Lansman, Ph.D. to its Advisory Board. Dr. Lansman is a Professor Emeritus of Cellular & Molecular Pharmacology in the School of Medicine, University of California, San Francisco. NeuroLight is developing breakthrough brain […]
Dr. Alexander Kott Joins Advisory Board of NeuroLight, Inc.
Pomona, New York — December 2, 2024 — NeuroLight, Inc., a pioneering neuromodulation medical device company, today announced that former Chief Scientist of the US Army Research Laboratory, Dr. Alexander Kott, Ph.D., joined its Advisory Board. NeuroLight is revolutionizing brain sensory stimulation technology, enabling the transfer of optimal brain states from one person to another. […]
Dr. Scott Parazynski Joins Advisory Board of NeuroLight, Inc.
Dr. Scott Parazynski, an astronaut, inventor, and medical expert, has joined the Advisory Board of NeuroLight, Inc., a neuromodulation medical device company We are thrilled to welcome Dr. Parazynski to our Advisory Board. His unique blend of scientific, medical, and entrepreneurial expertise will provide invaluable guidance to our company.”— Alexander Poltorak NeuroLight, Inc., a pioneering […]
NeuroLight, Inc. Successfully Completes Phase I NSF/SBIR Grant, Paving the Way for Innovative Sleep Therapy
NeuroLight, Inc. has successfully completed its Phase I NSF/SBIR grant and submitted Outcomes Report, detailing progress in developing neromod sleep technology.